Source link : https://newshealth.biz/health-news/apixaban-snags-a-win-in-head-to-head-trial-of-direct-oral-anticoagulants/
The COBRRA trial directly tested apixaban and rivaroxaban, the oral anticoagulants most frequently used to treat acute venous thromboembolism. The risk of clinically relevant bleeding came out significantly lower with apixaban than with rivaroxaban during the 3-month treatment period. The study-specific dosing regimen may have played a role in the results, however. One winner emerged […]
The post Apixaban Snags a Win in Head-to-Head Trial of Direct Oral Anticoagulants first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-11 21:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8